Mechanistic insights into the interactions between cancer drivers and the tumour immune microenvironment
H. Misetic, M. R. Keddar, J.-P. Jeannon, F. D. Ciccarelli
The paper identifies 477 TIME drivers across 32 cancer types, showing their role in cancer evolution and predicting immunotherapy response, with a focus on HNSC.
bioRxiv · Jan 24, 2023 · PreprintCancer Biology